niftify.in

niftify.in

Latest Beta Drugs News

Comprehensive Beta Drugs Stock Updates: Catch up on the latest Beta Drugs stock news and industry insights. Get quick details on Beta Drugs stock buybacks,Beta Drugs results, Beta Drugs company analysis, Beta Drugs live prices, Beta Drugs dividends, Beta Drugs bonus share, board meetings, lifetime highs, Beta Drugs targets, lows, and growth stories with AI.

A cryptic post on OpenAI newsroom account on X persuaded users that they could claim a share of its initial supply and gain uninterrupted access to upcoming beta programs. It featured a 'CLAIM $OPENAI' button that lured users to connect their cryptocurrency wallets.
The Economic Times

The Economic Times

OpenAI’s newsroom account on X hacked

A cryptic post on OpenAI newsroom account on X persuaded users that they could claim a share of its initial supply and gain uninterrupted access to upcoming beta programs. It featured a 'CLAIM $OPENAI' button that lured users to connect their cryptocurrency wallets.

Tue, Sep 24, 2024

By minimizing exposure to higher volatility securities, the Nifty 100 Low Volatility 30 Total Return Index (TRI) smoothes out portfolio movements and limits downside risk in times of market corrections.
The Economic Times

The Economic Times

Maximizing gains while minimizing risks: The smart beta advantage

By minimizing exposure to higher volatility securities, the Nifty 100 Low Volatility 30 Total Return Index (TRI) smoothes out portfolio movements and limits downside risk in times of market corrections.

Mon, Sep 23, 2024

Jio Financial Limited is set to launch home loan products after debuting their secured lending and digital banking solutions. The company, a Reliance Industries arm, is also progressing in its joint venture with BlackRock and expanding insurance offerings. The beta JioFinance app has hit 1 million downloads.
The Economic Times

The Economic Times

Jio Financial to launch home loans soon

Jio Financial Limited is set to launch home loan products after debuting their secured lending and digital banking solutions. The company, a Reliance Industries arm, is also progressing in its joint venture with BlackRock and expanding insurance offerings. The beta JioFinance app has hit 1 million downloads.

Fri, Aug 30, 2024

Fund houses are adopting innovative strategies, such as Smart Beta and equal-weight investments, to attract investors seeking higher returns
Business Line

Business Line

Passive fund boom: 63 new NFOs launched in 7 months, AUM hits ₹10.95 lakh crore

Fund houses are adopting innovative strategies, such as Smart Beta and equal-weight investments, to attract investors seeking higher returns

Mon, Aug 26, 2024

Rajesh Bhatia, CIO of ITI MF, addressed the future growth and current valuations in sectors like defence, railways, domestic pharma, and electric vehicles. He cautioned about the high beta and cyclical nature of capital market plays. Bhatia also noted the ongoing structural shifts and challenges within these sectors, urging a careful approach to investments.
The Economic Times

The Economic Times

Should you be booking profit in capital market plays? This is what Rajesh Bhatia has to say

Rajesh Bhatia, CIO of ITI MF, addressed the future growth and current valuations in sectors like defence, railways, domestic pharma, and electric vehicles. He cautioned about the high beta and cyclical nature of capital market plays. Bhatia also noted the ongoing structural shifts and challenges within these sectors, urging a careful approach to investments.

Mon, Aug 26, 2024

Ipca Laboratories introduced Diulcus, a topical gel designed to treat diabetic foot ulcers, priced at Rs 1365 per pack. The gel is based on repurposed beta blocker Esmolol. Approved after clinical trials, the product showed promising ulcer closure rates, with Ipca targeting a substantial market share within three years.
The Economic Times

The Economic Times

Ipca launches new topical therapy against diabetic foot ulcer

Ipca Laboratories introduced Diulcus, a topical gel designed to treat diabetic foot ulcers, priced at Rs 1365 per pack. The gel is based on repurposed beta blocker Esmolol. Approved after clinical trials, the product showed promising ulcer closure rates, with Ipca targeting a substantial market share within three years.

Fri, Aug 16, 2024

Zomato shares surged 21% since June 4, outperforming the Sensex's 11% rise. Analysts predict up to 20% additional gains. The stock hit a 52-week high of Rs 213.80, closing at Rs 208.15. Momentum indicators show shares trading above 50 and 200-day SMAs with a 1-year beta at 0.6. Axis Securities noted sustained buying activity and net profit.
The Economic Times

The Economic Times

Momentum Pick: Will Zomato's 21% returns over a month and technical breakouts trigger another leg of rally?

Zomato shares surged 21% since June 4, outperforming the Sensex's 11% rise. Analysts predict up to 20% additional gains. The stock hit a 52-week high of Rs 213.80, closing at Rs 208.15. Momentum indicators show shares trading above 50 and 200-day SMAs with a 1-year beta at 0.6. Axis Securities noted sustained buying activity and net profit.

Thu, Jul 4, 2024